Argent Biopharma Ltd RGTLF
Trading Information
- Previous Close Price
- $0.03
- Day Range
- $0.01–0.01
- 52-Week Range
- $0.01–0.10
- Bid/Ask
- $0.00 / $44,000.05
- Shares Outstanding
- 117.86M
- Market Cap
- $611,102.71
- Volume/Avg
- 953 / 2,089
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 4.37
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Argent Biopharma Ltd is a revenue-generating, clinical-stage biopharmaceutical company focused on the development and commercialization of nano-engineered therapeutics targeting neurological and immunemediated disorders. Its assets, CannEpil and CimetrA, are for drug-resistant epilepsy and inflammatory conditions, respectively. The company leverages proprietary nano-delivery technologies designed to optimize bioavailability and tissue penetration, including across the blood-brain barrier and pulmonary interfaces. The company operates in a single segment. Geographically, it operates in Malta, Slovenia, UK, and Australia, with the majority of revenue deriving from Slovenia.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- —
- Website
- https://www.argentbiopharma.com
Valuation
|
Metric
|
RGTLF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 4.37 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
RGTLF
|
|---|---|
Quick Ratio | 0.04 |
Current Ratio | 0.05 |
Interest Coverage | — |
Quick Ratio
RGTLF
Profitability
|
Metric
|
RGTLF
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
RGTLF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|n??FPs^& | LOCK|d<zFp | $70B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|h^yrm%@ | LOCK|Rh#< | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|$$&vjtb | LOCK|b#H | $45B | |||
| Zoetis Inc Class A
ZTS
| LOCK|%<#@<&#< | LOCK|lc | $33B | |||
| Viatris Inc
VTRS
| LOCK|@>L?M< | LOCK|GcM | $21B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|^^Z | LOCK|&@m | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|Sk??R! | LOCK|qw@ | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|vbm<VgQ | LOCK|RJk | $6B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|&<z?vN | LOCK|v!>&g | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|&r##g<@ | LOCK|!Lr | $2B |
United States